Published in J Virol on November 01, 1986
Rotavirus gene structure and function. Microbiol Rev (1989) 6.95
The rhesus rotavirus gene encoding protein VP3: location of amino acids involved in homologous and heterologous rotavirus neutralization and identification of a putative fusion region. Proc Natl Acad Sci U S A (1988) 4.23
Rotavirus isolate WI61 representing a presumptive new human serotype. J Clin Microbiol (1987) 3.58
Antigenic relationships among human rotaviruses as determined by outer capsid protein VP4. Proc Natl Acad Sci U S A (1990) 2.90
Evidence of high-frequency genomic reassortment of group A rotavirus strains in Bangladesh: emergence of type G9 in 1995. J Clin Microbiol (1999) 2.31
Synthesis and immunogenicity of the rotavirus major capsid antigen using a baculovirus expression system. J Virol (1987) 2.29
Detection and characterization of novel rotavirus strains in the United States. J Clin Microbiol (1998) 2.16
Functional and topographical analyses of epitopes on the hemagglutinin (VP4) of the simian rotavirus SA11. J Virol (1988) 2.08
Role of VP3 in human rotavirus internalization after target cell attachment via VP7. J Virol (1988) 2.01
Antibodies to the trypsin cleavage peptide VP8 neutralize rotavirus by inhibiting binding of virions to target cells in culture. J Virol (1991) 1.99
Infection immunity of piglets to either VP3 or VP7 outer capsid protein confers resistance to challenge with a virulent rotavirus bearing the corresponding antigen. J Virol (1988) 1.96
Rotavirus serotypes 6 and 10 predominate in cattle. J Clin Microbiol (1990) 1.81
The rhesus rotavirus outer capsid protein VP4 functions as a hemagglutinin and is antigenically conserved when expressed by a baculovirus recombinant. J Virol (1989) 1.80
Temporal and geographical distributions of human rotavirus serotypes, 1983 to 1988. J Clin Microbiol (1989) 1.67
A novel group A rotavirus G serotype: serological and genomic characterization of equine isolate FI23. J Clin Microbiol (1991) 1.59
Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to the heterotypic neutralization domain of VP7 and the VP8 fragment of VP4. J Clin Microbiol (1989) 1.58
Relative concentrations of serum neutralizing antibody to VP3 and VP7 proteins in adults infected with a human rotavirus. J Virol (1988) 1.49
Surveillance of rotavirus strains in the United States: identification of unusual strains. The National Rotavirus Strain Surveillance System collaborating laboratories. J Clin Microbiol (2000) 1.47
Serologic analysis of human rotavirus serotypes P1A and P2 by using monoclonal antibodies. J Clin Microbiol (1993) 1.46
Rotavirus capsid protein VP5* permeabilizes membranes. J Virol (1999) 1.42
Immunization with baculovirus-expressed VP4 protein passively protects against simian and murine rotavirus challenge. J Virol (1990) 1.37
Localization of rotavirus VP4 neutralization epitopes involved in antibody-induced conformational changes of virus structure. J Virol (1994) 1.35
Protection between different serotypes of bovine rotavirus in gnotobiotic calves: specificity of serum antibody and coproantibody responses. J Clin Microbiol (1987) 1.33
Diversity of rotavirus strains among children with acute diarrhea in China: 1998-2000 surveillance study. J Clin Microbiol (2002) 1.29
Rotavirus-specific cytotoxic T lymphocytes appear at the intestinal mucosal surface after rotavirus infection. J Virol (1989) 1.29
Cleavage of rhesus rotavirus VP4 after arginine 247 is essential for rotavirus-like particle-induced fusion from without. J Virol (1998) 1.27
Heterogeneity and temporal dynamics of evolution of G1 human rotaviruses in a settled population. J Virol (2006) 1.25
Reactivity of VP4-specific monoclonal antibodies to a serotype 4 porcine rotavirus with distinct serotypes of human (symptomatic and asymptomatic) and animal rotaviruses. J Clin Microbiol (1989) 1.23
Memory and distribution of virus-specific cytotoxic T lymphocytes (CTLs) and CTL precursors after rotavirus infection. J Virol (1991) 1.22
DNA amplification-restricted transcription-translation: rapid analysis of rhesus rotavirus neutralization sites. Proc Natl Acad Sci U S A (1990) 1.20
Rotavirus vaccines: an overview. Clin Microbiol Rev (1996) 1.19
Characterization of serotype G9 rotavirus strains isolated in the United States and India from 1993 to 2001. J Clin Microbiol (2003) 1.19
Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein. J Virol (1999) 1.18
VP4 monotype specificities among porcine rotavirus strains of the same VP4 serotype. J Virol (1991) 1.16
Neutralizing antibodies to heterologous animal rotavirus serotypes 5, 6, 7, and 10 in sera from Ecuadorian children. J Clin Microbiol (1991) 1.14
A serotype 10 human rotavirus. J Clin Microbiol (1992) 1.14
Evidence that resolution of rotavirus infection in mice is due to both CD4 and CD8 cell-dependent activities. J Virol (1997) 1.13
Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial. BMC Infect Dis (2012) 1.12
Rotavirus YM gene 4: analysis of its deduced amino acid sequence and prediction of the secondary structure of the VP4 protein. J Virol (1991) 1.09
Virus-like particle-induced fusion from without in tissue culture cells: role of outer-layer proteins VP4 and VP7. J Virol (1997) 1.07
Rotavirus serotype G9 strains belonging to VP7 gene phylogenetic sequence lineage 1 may be more suitable for serotype G9 vaccine candidates than those belonging to lineage 2 or 3. J Virol (2004) 1.06
The rhesus rotavirus gene encoding VP4 is a major determinant in the pathogenesis of biliary atresia in newborn mice. J Virol (2011) 1.04
Isolation of an avianlike group A rotavirus from a calf with diarrhea. J Clin Microbiol (1992) 1.03
VP7 and VP4 genotyping of human group A rotavirus in Buenos Aires, Argentina. J Clin Microbiol (2000) 0.99
Polypeptide specificity of antiviral serum antibodies in children naturally infected with human rotavirus. J Virol (1990) 0.99
Noninfectious rotavirus (strain RRV) induces an immune response in mice which protects against rotavirus challenge. J Clin Microbiol (1989) 0.98
Serum-neutralizing antibody to VP4 and VP7 proteins in infants following vaccination with WC3 bovine rotavirus. J Virol (1990) 0.98
Comparative studies of the antigenic polypeptide species VP4, VP6, and VP7 of three strains of bovine rotavirus. J Clin Microbiol (1989) 0.96
VP4-specific intestinal antibody response to rotavirus in a murine model of heterotypic infection. J Virol (1991) 0.96
Serotypic analysis of VP3 and VP7 neutralization escape mutants of rhesus rotavirus. J Virol (1988) 0.96
Comparisons of rotavirus VP7-typing monoclonal antibodies by competition binding assay. J Clin Microbiol (1992) 0.96
Discrete domains within the rotavirus VP5* direct peripheral membrane association and membrane permeability. J Virol (2004) 0.89
Genetic diversity of circulating rotavirus strains in Tanzania prior to the introduction of vaccination. PLoS One (2014) 0.89
Analysis of homotypic and heterotypic serum immune responses to rotavirus proteins following primary rotavirus infection by using the radioimmunoprecipitation technique. J Clin Microbiol (1993) 0.88
Identification of VP7 epitopes associated with protection against human rotavirus illness or shedding in volunteers. J Virol (1992) 0.87
Human rotavirus K8 strain represents a new VP4 serotype. J Virol (1993) 0.87
Characterization of serum antibody responses to natural rotavirus infections in children by VP7-specific epitope-blocking assays. J Clin Microbiol (1992) 0.86
Characterization of full-length and polymerase chain reaction-derived partial-length Gottfried and OSU gene 4 probes for serotypic differentiation of porcine rotaviruses. J Clin Microbiol (1992) 0.86
Protective immunity to rotavirus shedding in the absence of interleukin-6: Th1 cells and immunoglobulin A develop normally. J Virol (2000) 0.86
Evidence for two serotype G3 subtypes among equine rotaviruses. J Clin Microbiol (1992) 0.86
Homotypic and heterotypic serological responses to rotavirus neutralization epitopes in immunologically naive and experienced animals. J Clin Microbiol (1991) 0.84
Analysis of serotypes and electropherotypes of equine rotaviruses isolated in the United States. J Clin Microbiol (1991) 0.84
VP4 serotype of the Gottfried strain of porcine rotavirus. J Clin Microbiol (1993) 0.83
Bovine rotavirus V1005 a P5, not a P12, type like all viruses in a German survey. J Clin Microbiol (1994) 0.82
Oral vaccination with the porcine rotavirus VP4 outer capsid protein expressed by Lactococcus lactis induces specific antibody production. J Biomed Biotechnol (2010) 0.81
The global spread of rotavirus G10 strains: Detection in Ghanaian children hospitalized with diarrhea. J Infect Dis (2010) 0.80
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Polyoma transformation of hamster cell clones--an investigation of genetic factors affecting cell competence. Virology (1962) 24.93
Human reovirus-like agent as the major pathogen associated with "winter" gastroenteritis in hospitalized infants and young children. N Engl J Med (1976) 7.57
Serotypic similarity and diversity of rotaviruses of mammalian and avian origin as studied by plaque-reduction neutralization. J Infect Dis (1984) 7.16
Genes of human (strain Wa) and bovine (strain UK) rotaviruses that code for neutralization and subgroup antigens. Virology (1981) 6.94
Independent segregation of two antigenic specificities (VP3 and VP7) involved in neutralization of rotavirus infectivity. Proc Natl Acad Sci U S A (1985) 5.94
Production and preliminary characterization of monoclonal antibodies directed at two surface proteins of rhesus rotavirus. J Virol (1983) 5.44
Rotaviruses: a review. Curr Top Microbiol Immunol (1983) 5.24
Identification of the rotaviral gene that codes for hemagglutination and protease-enhanced plaque formation. Virology (1983) 5.13
Plaque assay of neonatal calf diarrhea virus and the neutralizing antibody in human sera. J Clin Microbiol (1977) 5.01
In vitro transcription and translation of simian rotavirus SA11 gene products. J Virol (1980) 4.40
Identification of the two rotavirus genes determining neutralization specificities. J Virol (1986) 4.35
A candidate for a new serotype of human rotavirus. J Virol (1985) 4.09
A two-year study of bacterial, viral, and parasitic agents associated with diarrhea in rural Bangladesh. J Infect Dis (1980) 3.96
Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine. Lancet (1984) 3.55
Use of transcription probes for genotyping rotavirus reassortants. Virology (1982) 3.23
Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to surface proteins vp3 and vp7. J Virol (1986) 3.17
Preparation and characterization of neutralizing monoclonal antibodies with different reactivity patterns to human rotaviruses. J Gen Virol (1985) 3.12
Molecular basis of rotavirus virulence: role of gene segment 4. J Virol (1986) 3.08
Serotypic characterization of rotaviruses derived from asymptomatic human neonatal infections. J Clin Microbiol (1985) 2.47
Serotype-specific glycoprotein of simian 11 rotavirus: coding assignment and gene sequence. Proc Natl Acad Sci U S A (1983) 2.46
Immunogenicity and safety of live oral attenuated bovine rotavirus vaccine strain RIT 4237 in adults and young children. Lancet (1983) 2.20
Protection against rotavirus-induced gastroenteritis in a murine model by passively acquired gastrointestinal but not circulating antibodies. J Virol (1985) 2.06
Response of mice to rotaviruses of bovine or primate origin assessed by radioimmunoassay, radioimmunoprecipitation, and plaque reduction neutralization. Infect Immun (1983) 2.06
Preliminary characterization of an epitope involved in neutralization and cell attachment that is located on the major bovine rotavirus glycoprotein. J Virol (1985) 1.97
Oral administration of human rotavirus to volunteers: induction of illness and correlates of resistance. J Infect Dis (1983) 1.94
A murine model for oral infection with a primate rotavirus (simian SA11). J Virol (1984) 1.91
Cultivation and characterization of three strains of murine rotavirus. J Virol (1986) 1.90
The cultivation of human rotavirus, strain 'Wa', to high titer in cell culture and characterization of the viral structural polypeptides. J Virol Methods (1983) 1.76
Maternal antibody-mediated protection against gastroenteritis due to rotavirus in newborn mice is dependent on both serotype and titer of antibody. J Infect Dis (1985) 1.48
Extragenic suppression of temperature-sensitive phenotype in reovirus: mapping suppressor mutations. Virology (1984) 1.25
Semiautomatic apparatus for milking mice. J Natl Cancer Inst (1967) 1.00
Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J Clin Microbiol (1990) 10.23
Serotypic similarity and diversity of rotaviruses of mammalian and avian origin as studied by plaque-reduction neutralization. J Infect Dis (1984) 7.16
Genes of human (strain Wa) and bovine (strain UK) rotaviruses that code for neutralization and subgroup antigens. Virology (1981) 6.94
Pathogenic mycoplasmas: cultivation and vertebrate pathogenicity of a new spiroplasma. Science (1977) 5.64
Production and preliminary characterization of monoclonal antibodies directed at two surface proteins of rhesus rotavirus. J Virol (1983) 5.44
Human rotavirus type 2: cultivation in vitro. Science (1980) 5.22
Definition of human rotavirus serotypes by plaque reduction assay. Infect Immun (1982) 5.19
Enzyme-linked immunosorbent assay for detection of Escherichia coli heat-labile enterotoxin. J Clin Microbiol (1977) 5.17
Identification of the rotaviral gene that codes for hemagglutination and protease-enhanced plaque formation. Virology (1983) 5.13
Direct isolation in cell culture of human rotaviruses and their characterization into four serotypes. J Clin Microbiol (1983) 4.88
Epidemiology of human rotavirus Types 1 and 2 as studied by enzyme-linked immunosorbent assay. N Engl J Med (1978) 4.73
Direct serotyping of human rotavirus in stools by an enzyme-linked immunosorbent assay using serotype 1-, 2-, 3-, and 4-specific monoclonal antibodies to VP7. J Infect Dis (1987) 4.64
Epidemiology of Norwalk gastroenteritis and the role of Norwalk virus in outbreaks of acute nonbacterial gastroenteritis. Ann Intern Med (1982) 4.54
Rescue of noncultivatable human rotavirus by gene reassortment during mixed infection with ts mutants of a cultivatable bovine rotavirus. Proc Natl Acad Sci U S A (1981) 4.47
Identification of the two rotavirus genes determining neutralization specificities. J Virol (1986) 4.35
Gene coding assignments for growth restriction, neutralization and subgroup specificities of the W and DS-1 strains of human rotavirus. J Gen Virol (1983) 4.25
The rhesus rotavirus gene encoding protein VP3: location of amino acids involved in homologous and heterologous rotavirus neutralization and identification of a putative fusion region. Proc Natl Acad Sci U S A (1988) 4.23
Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses. J Virol (1994) 4.21
Solid-phase microtiter radioimmunoassay for detection of the Norwalk strain of acute nonbacterial, epidemic gastroenteritis virus and its antibodies. J Med Virol (1978) 4.06
Structure of hepatitis B Dane particle DNA and nature of the endogenous DNA polymerase reaction. J Virol (1977) 4.02
Antigenic characterization of human and animal rotaviruses by immune adherence hemagglutination assay (IAHA): evidence for distinctness of IAHA and neutralization antigens. Infect Immun (1981) 3.83
Antigenic mapping of the surface proteins of rhesus rotavirus. Virology (1986) 3.80
Rotavirus isolate WI61 representing a presumptive new human serotype. J Clin Microbiol (1987) 3.58
Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers. Proc Natl Acad Sci U S A (1999) 3.30
CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity (2000) 3.28
Comparison of the ribonucleic acid polymerases of two rhabdoviruses, Kern Canyon virus and vesicular stomatitis virus. J Virol (1971) 3.26
Use of transcription probes for genotyping rotavirus reassortants. Virology (1982) 3.23
Specific enzyme-linked immunoassay for rotavirus serotypes 1 and 3. J Clin Microbiol (1985) 3.23
Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to surface proteins vp3 and vp7. J Virol (1986) 3.17
Distinctive ribonucleic acid patterns of human rotavirus subgroups 1 and 2. Infect Immun (1981) 3.13
Molecular basis of rotavirus virulence: role of gene segment 4. J Virol (1986) 3.08
Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science (1996) 3.07
Rescue and serotypic characterization of noncultivable human rotavirus by gene reassortment. Infect Immun (1982) 2.97
Ultrastructural localization of rotavirus antigens using colloidal gold. Virus Res (1984) 2.95
Reassortant rotaviruses as potential live rotavirus vaccine candidates. J Virol (1985) 2.95
Three-dimensional structure of rhesus rotavirus by cryoelectron microscopy and image reconstruction. J Cell Biol (1990) 2.83
Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis. N Engl J Med (1976) 2.80
Detection of Norwalk virus in stool specimens by reverse transcriptase-polymerase chain reaction and nonradioactive oligoprobes. J Clin Microbiol (1992) 2.77
Infectious rotavirus enters cells by direct cell membrane penetration, not by endocytosis. J Virol (1988) 2.72
Microtiter solid-phase radioimmunoassay for detection of Escherichia coli heat-labile enterotoxin. Infect Immun (1977) 2.72
Phosphoproteins, structural components of rhabdoviruses. Virology (1973) 2.70
Immune response in silico (IRIS): immune-specific genes identified from a compendium of microarray expression data. Genes Immun (2005) 2.69
Multiple-challenge study of host susceptibility to Norwalk gastroenteritis in US adults. J Infect Dis (1990) 2.63
Proteins of Norwalk virus. J Virol (1981) 2.59
Viral gastroenteritis. N Engl J Med (1991) 2.58
CCR7 expression and memory T cell diversity in humans. J Immunol (2001) 2.42
The isolation and characterization of a Norwalk virus-specific cDNA. J Clin Invest (1991) 2.42
Approaches to immunization of infants and young children against gastroenteritis due to rotaviruses. Rev Infect Dis (1980) 2.39
Bonzo/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential. J Clin Invest (2001) 2.23
Group A rotaviruses produce extrahepatic biliary obstruction in orally inoculated newborn mice. Pediatr Res (1993) 2.22
Detection and characterization of novel rotavirus strains in the United States. J Clin Microbiol (1998) 2.16
Identification of the simian rotavirus SA11 genome segment 3 product. Virology (1988) 2.10
Functional and topographical analyses of epitopes on the hemagglutinin (VP4) of the simian rotavirus SA11. J Virol (1988) 2.08
Immune response and prevalence of antibody to Norwalk enteritis virus as determined by radioimmunoassay. J Clin Microbiol (1979) 2.06
Protection against rotavirus-induced gastroenteritis in a murine model by passively acquired gastrointestinal but not circulating antibodies. J Virol (1985) 2.06
Response of mice to rotaviruses of bovine or primate origin assessed by radioimmunoassay, radioimmunoprecipitation, and plaque reduction neutralization. Infect Immun (1983) 2.06
Role of B cells and cytotoxic T lymphocytes in clearance of and immunity to rotavirus infection in mice. J Virol (1995) 2.06
Role of Norwalk virus in outbreaks of nonbacterial gastroenteritis. J Infect Dis (1979) 2.05
Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus. J Virol (1994) 2.03
Antibodies to the trypsin cleavage peptide VP8 neutralize rotavirus by inhibiting binding of virions to target cells in culture. J Virol (1991) 1.99
Characterization of homotypic and heterotypic VP7 neutralization sites of rhesus rotavirus. Virology (1988) 1.98
Oral administration of human rotavirus to volunteers: induction of illness and correlates of resistance. J Infect Dis (1983) 1.94
Analysis of astrovirus serotype 1 RNA, identification of the viral RNA-dependent RNA polymerase motif, and expression of a viral structural protein. J Virol (1994) 1.94
The VP8 fragment of VP4 is the rhesus rotavirus hemagglutinin. Virology (1991) 1.92
Detection of homologous RNA sequences among six rhabdovirus genomes. J Virol (1974) 1.91
A murine model for oral infection with a primate rotavirus (simian SA11). J Virol (1984) 1.91
Cultivation and characterization of three strains of murine rotavirus. J Virol (1986) 1.90
In vitro transcription of two human rotaviruses. J Virol (1982) 1.88
Diversity of rotavirus serotypes in Mexican infants with gastroenteritis. J Clin Microbiol (1990) 1.85
Experimental infection of chimpanzees with the Norwalk agent of epidemic viral gastroenteritis. J Med Virol (1978) 1.84
Prophylactic doxycycline for travelers' diarrhea: results of a prospective double-blind study of Peace Corps volunteers in Morocco. Gastroenterology (1979) 1.84
Norwalk gastrointestinal illness: an outbreak associated with swimming in a recreational lake and secondary person-to-person transmission. Am J Epidemiol (1982) 1.81
Rotavirus serotypes 6 and 10 predominate in cattle. J Clin Microbiol (1990) 1.81
The rhesus rotavirus outer capsid protein VP4 functions as a hemagglutinin and is antigenically conserved when expressed by a baculovirus recombinant. J Virol (1989) 1.80
Norwalk virus gastroenteritis following raw oyster consumption. Am J Epidemiol (1982) 1.77
The cultivation of human rotavirus, strain 'Wa', to high titer in cell culture and characterization of the viral structural polypeptides. J Virol Methods (1983) 1.76
Analyses of homologous rotavirus infection in the mouse model. Virology (1995) 1.75
Antibody to Mycoplasma pneumoniae in nasal secretions and sputa of experimentally infected human volunteers. Infect Immun (1973) 1.72
Prevalence of antibody to the Norwalk agent by a newly developed immune adherence hemagglutination assay. J Med Virol (1978) 1.72
Molecular determinant of rotavirus neutralization and protection. Adv Virus Res (1989) 1.65
Ampicillin-resistant, beta-lactamase-negative haemophilus influenzae type b. Pediatrics (1982) 1.64
Murine rotavirus genes encoding outer capsid proteins VP4 and VP7 are not major determinants of host range restriction and virulence. J Virol (1993) 1.64
Immunity to homologous rotavirus infection in adult mice. Trends Microbiol (2000) 1.62
Both surface proteins (VP4 and VP7) of an asymptomatic neonatal rotavirus strain (I321) have high levels of sequence identity with the homologous proteins of a serotype 10 bovine rotavirus. Virology (1993) 1.58
Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to the heterotypic neutralization domain of VP7 and the VP8 fragment of VP4. J Clin Microbiol (1989) 1.58
Genetic mapping indicates that VP4 is the rotavirus cell attachment protein in vitro and in vivo. J Virol (1996) 1.56
Prevalence of antibody to the Norwalk virus in various countries. Infect Immun (1979) 1.54